Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
 |
The New Vision (Uganda) - Wednesday, May 10, 2000
Briefing a 12-man Ghanian AIDS delegation, scientists at the centre said the last volunteer received the last injection in February, bringing an end to the year-long exercise. Each volunteer got four injections of either the test vaccine or one of two comparison substances.
Dr. Peter Mugyenyi, the JCRC Director, said they would continue monitoring the volunteers.
The vaccine is manufactured by Pasteur Merieux Connaught. The trial, funded by the US National Institute for Allergy and Infectious Diseases, is a collaboration between Ugandan institutions and the US John Hopkins University.
000510
NV000502
Copyright © 2000 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .